Evidence map›Paper›PMID 19952273›Full record

ArticleEndocrinology2010

Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation.

Elisabetta Vegeto, Salvatore Cuzzocrea, Concetta Crisafulli, Emanuela Mazzon, Angelo Sala, Andreè Krust, Adriana Maggi

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. The SARS-CoV-2 spike protein binds and modulates estrogen receptors.bioRxiv : the preprint server for biology · 2022
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Elisabetta VegetoCenter of Excellence on Neurodegenerative Disease, University of Milan, Via Balzaretti, 200133 Milan, Italy. elisabetta.vegeto@unimi.it
Salvatore Cuzzocrea
Concetta Crisafulli
Emanuela Mazzon
Angelo Sala
Andreè Krust
Adriana Maggi
University of Messina · ITUniversity of Milan · ITInstitut Clinique de la Souris · FR

Funding

Menopause: Decreased Response to Increasing InflammationR01AG027713 · NIA · UNIVERSITY OF MILAN · PI MAGGI, ADRIANA CATERINA · 2006 to 2010
$916k
NIA NIH HHS R01 AG027713NIA NIH HHS R01-AG027713-01
6 · The paper itself

Abstract

Accumulating evidence shows that estrogens are protective factors in inflammatory lung diseases and are involved in the gender-related incidence of these pathologies. The aim of this study was to identify which estrogen receptor (ER), ER-alpha and/or ER beta, mediates hormone antiinflammatory effects in lung and how gender or aging modify this effect. Acute lung inflammation in wild type, ER alpha or ER beta knockout animals was induced by pleural injection of carrageenan; female mice were used and sham operated, ovariectomized, or ovariectomized and treated with 17beta-estradiol (E(2)) before carrageenan. Our data show that ER alpha, and not ER beta, mediates E(2)-induced reduction of the inflammatory response. By real-time PCR and immunohistochemistry assays, we demonstrate ER alpha expression in the resident and infiltrated inflammatory cells of the lung, in which ER beta could not be detected. In these cells, E(2)-mediated reduction in the expression of inflammatory mediators was also due to ER alpha. In parallel, we observed that female mice were more prone to inflammation as compared with males, suggesting a gender-related difference in lung susceptibility to inflammatory stimuli, whereas the effect of E(2) was similar in the two sexes. Interestingly, aging results in a strong increase in the inflammatory response in both sexes and in the disruption E(2)/ER alpha signaling pathway. In conclusion, our data reveal that E(2) is able to regulate lung inflammation in a gender-unrelated, age-restricted manner. The specific involvement of ER alpha in hormone action opens new ways to identify drug targets that limit the inflammatory component of lung pathologies.

Indexed as

Drug Delivery SystemsAgingAnimalsAnti-Inflammatory AgentsCells, CulturedEstrogen Receptor alphaEstrogen Receptor betaEstrogensFemaleInflammation MediatorsMaleMiceMice, Inbred C57BLMice, KnockoutOvariectomyPneumoniaAnti-Inflammatory AgentsEstrogen Receptor alphaEstrogen Receptor betaEstrogensInflammation Mediators

Identifiers

PMID19952273
PMCPMC2803150
OpenAlexW2138545949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.